logo

Oramed Pharmaceuticals Inc. (ORMP)



Trade ORMP now with
  Date
  Headline
5/25/2021 8:44:34 AM Oramed Says Phase 3 Studies Of Oral Insulin Underway And On Schedule
3/23/2021 9:10:24 AM Oramed Initiates Second Phase 3 Oral Insulin Study For Type 2 Diabetes
3/19/2021 8:48:20 AM Oramed To Form JV, Oravax Medical, To Develop Oral COVID-19 Vaccines; Stock Up
1/21/2021 8:36:49 AM Oramed Says Doses Patients Across Multiple Sites In Phase 3 Oral Insulin Study
12/23/2020 8:26:45 AM Oramed Announces Positive First In Human Data From Oral Leptin Study
12/2/2020 8:27:03 AM Oramed Screens First Patients In Global Trial Of Oral Insulin Capsule ORMD-0801 For Nonalcoholic Steatohepatitis
11/24/2020 8:12:38 AM Oramed Says Screened First Patients In Global Phase 3 Trials Of Oral Insulin Capsule ORMD-0801 For Type 2 Diabetes
10/16/2020 9:01:15 AM Oramed Plans To Commence Patient Enrollment For Two Phase 3 Studies This Quarter
7/15/2020 8:57:24 AM Oramed Says FDA Provided Positive Feedback During End Of Phase 2 Meeting For Oral Insulin
6/15/2020 8:31:16 AM Oramed Announces Positive Initial Clinical Trial Results For Treatment Of NASH With Oral Insulin
4/7/2020 7:44:00 AM Oramed Says Patent In Canada Allowed For Oral Delivery Of Proteins
3/19/2020 8:46:53 AM Oramed Announces Positive Feedback From Its Initial End-of-Phase 2 Meeting With FDA
2/27/2020 9:29:26 AM Oramed Pharmaceuticals Prices Public Offering Of 5.25 Mln Shares At $4.00 Per Share